PL2328594T3 - Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS - Google Patents

Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS

Info

Publication number
PL2328594T3
PL2328594T3 PL09786159.5T PL09786159T PL2328594T3 PL 2328594 T3 PL2328594 T3 PL 2328594T3 PL 09786159 T PL09786159 T PL 09786159T PL 2328594 T3 PL2328594 T3 PL 2328594T3
Authority
PL
Poland
Prior art keywords
stem cells
adipose tissue
cells derived
stromal stem
derived form
Prior art date
Application number
PL09786159.5T
Other languages
English (en)
Inventor
Mario Delgado
Elena Gonzalez-Rey
Dirk Büscher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2328594T3 publication Critical patent/PL2328594T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
PL09786159.5T 2008-08-04 2009-08-03 Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS PL2328594T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0814249.9A GB0814249D0 (en) 2008-08-04 2008-08-04 Uses of mesenchymal stem cells

Publications (1)

Publication Number Publication Date
PL2328594T3 true PL2328594T3 (pl) 2016-09-30

Family

ID=39767494

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09786159.5T PL2328594T3 (pl) 2008-08-04 2009-08-03 Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS

Country Status (12)

Country Link
US (2) US20120027730A1 (pl)
EP (2) EP3095449A1 (pl)
JP (3) JP6178970B2 (pl)
KR (2) KR101764643B1 (pl)
AU (1) AU2009278853B2 (pl)
CA (2) CA3034718A1 (pl)
DK (1) DK2328594T3 (pl)
ES (1) ES2575165T3 (pl)
GB (1) GB0814249D0 (pl)
HU (1) HUE029213T2 (pl)
PL (1) PL2328594T3 (pl)
WO (1) WO2010015929A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313805B1 (es) 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
NZ597975A (en) * 2009-07-09 2014-06-27 Tigenix S A Methods and compositions for use in cellular therapies
KR101900664B1 (ko) * 2011-01-12 2018-09-21 타이제닉스, 에스.에이.유. 자가면역 및 염증성 질환에서 림프내 투여를 위한 지방-유래 중간엽 줄기 세포
JP5932970B2 (ja) * 2011-04-06 2016-06-08 サンバイオ，インコーポレイティド 末梢免疫機能を調節するための方法及び組成物
US20140134140A1 (en) * 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
JP6643999B2 (ja) * 2013-11-04 2020-02-12 アイソポジェン ピーティーワイ リミテッド 細胞培養方法
WO2015120077A1 (en) * 2014-02-04 2015-08-13 Gonzalez Jose Javier Lopez Biologically optimized adult mesenchymal stem cells
JP6628253B2 (ja) * 2014-02-11 2020-01-08 ブレインストーム セル セラペウティクス リミテッド 細胞の適性を判定する方法
SG11201610844PA (en) * 2014-06-30 2017-01-27 Tigenix S A U Mesenchymal stromal cells for treating sepsis
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CN106042962A (zh) * 2016-06-18 2016-10-26 合肥松雷信息科技有限公司 一种充电桩底座
CN109803665A (zh) * 2016-10-18 2019-05-24 国立大学法人大阪大学 疾病治疗剂制备用试剂盒、疾病治疗剂和疾病治疗剂的制备方法
JP7248984B2 (ja) 2017-02-28 2023-03-30 ユニバーシティ デ ロライン 敗血症の治療のための、ワルトンジェリーから取得された間葉系幹細胞
AU2019370629A1 (en) * 2018-10-29 2021-05-20 Ottawa Hospital Research Institute Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof
CN112646773B (zh) * 2021-01-21 2021-12-21 华夏源(上海)生物科技有限公司 一种高效率的人间充质干细胞诱导分化成脂的方法
EP4331592A1 (en) 2021-05-13 2024-03-06 Stemmed Inc. Composition and use thereof
WO2023282423A1 (ko) * 2021-07-06 2023-01-12 건국대학교 산학협력단 중간엽 줄기세포, 이로부터 분리된 세포외 소포체, 및 이들의 용도
CN117224577B (zh) * 2023-09-21 2024-02-27 浙江大学 干细胞凋亡小体在制备治疗复发性流产的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
CA2521217C (en) * 2003-04-01 2013-05-14 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
EP2298862B1 (en) * 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
ES2589311T5 (es) * 2005-09-23 2020-02-14 Tigenix S A U Poblaciones de células que tienen actividad inmunorreguladora, método de aislamiento y usos
US20120269774A1 (en) * 2006-09-21 2012-10-25 Medistem Laboratories, Inc Allogeneic stem cell transplants in non-conditioned recipients
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells

Also Published As

Publication number Publication date
JP2011529957A (ja) 2011-12-15
WO2010015929A3 (en) 2010-04-29
KR101974842B1 (ko) 2019-05-03
EP3095449A1 (en) 2016-11-23
AU2009278853B2 (en) 2015-09-17
DK2328594T3 (en) 2016-04-04
EP2328594A2 (en) 2011-06-08
JP2016040256A (ja) 2016-03-24
CA2732908C (en) 2019-06-04
EP2328594B1 (en) 2016-03-16
ES2575165T3 (es) 2016-06-24
KR20110127111A (ko) 2011-11-24
KR20170098933A (ko) 2017-08-30
CA2732908A1 (en) 2010-02-11
CA3034718A1 (en) 2010-02-11
WO2010015929A2 (en) 2010-02-11
US20120027730A1 (en) 2012-02-02
JP6178970B2 (ja) 2017-08-16
JP2018080174A (ja) 2018-05-24
JP6285901B2 (ja) 2018-02-28
JP6755850B2 (ja) 2020-09-16
US20220088084A1 (en) 2022-03-24
GB0814249D0 (en) 2008-09-10
HUE029213T2 (en) 2017-02-28
AU2009278853A1 (en) 2010-02-11
KR101764643B1 (ko) 2017-09-05

Similar Documents

Publication Publication Date Title
PL2328594T3 (pl) Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS
HUS1800039I1 (hu) Zsírszövet-eredetû stromális õssejtek alkalmazása sipoly kezelésében
HK1196034A1 (zh) 細胞及組織的冷凍保存用組合物
HK1216883A1 (zh) 幹細胞培養
EP2183358A4 (en) PROCESS FOR THE PREPARATION OF DERMAL PAPER TISSUE EMPLOYING MESENCHYMAL STEM CELLS
IL204566A (en) Adherent cells from fat or placenta tissue for use in healing
EP2487236A4 (en) CULTURE SUPPORT FOR HUMAN PLURIPOTENTE STEM CELLS AND USE THEREOF
EP2326710A4 (en) THERAPEUTIC METHODS USING SUSPENSIONS OF CELLS FROM ADIPOSE TISSUES COMPRISING ADIPOCYTES
EP2294183A4 (en) MESENCHYMAL STEM CELLS, COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC TISSUE LESIONS
PL2283114T3 (pl) Traktowanie komórek pluripotencjalnych
EP2367931A4 (en) METHOD FOR OBTAINING DIFFERENTIATED CELLS FROM STEM CELLS
IL207036A0 (en) Stem cell aggregates and methods for making and using
HK1169993A1 (en) Hsl inhibitors useful in the treatment of diabetes hsl
IL205470A0 (en) Methods for co-culturing cord blood derived cells with menstrual stem cells
PT2337573E (pt) Soro de leite no tratamento de linfocitopenia
EP2170394A4 (en) REGULATORY T CELLS IN ADIPOSIVE TISSUE
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
EP2305223A4 (en) AGENT FOR THE ACTIVATION OF STEM CELLS
EP2327427A4 (en) CELL PREPARATION FOR BONE WEAVER AGENCY
ZA201206853B (en) Composition for use in water treatment
GB2473504B (en) Method for determining the suitability of compounds for use in treating bipolar disorder